STOCK TITAN

Lyell Immunopharma, Inc. (LYEL) Revenue by Year

LYEL

Lyell Immunopharma, Inc. generated $36K in revenue in fiscal year 2025. This represents a decrease of 41.0% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to $27K in revenue. The table below carries 7 fiscal years, from 2019 to 2025, and the quarters Lyell Immunopharma, Inc. has filed alongside them.

FY2025 annual
Revenue $36K
YoY -41.0%
5Y CAGR -65.9%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

LYEL Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-K
Revenue$27K$36K-41.0%$61K-53.1%$130K-99.8%$84.7M+695.1%$10.7M+37.3%$7.8M+1080.5%$657K

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

LYEL Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Revenue$4K-50.0%$2K-71.4%$6K-45.5%$15K-55.9%$8K-38.5%$7K+133.3%$11K-15.4%$34K+36.0%$13K-51.9%$3K-95.4%$13K-100.0%$25K+733.3%

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More Lyell Immunopharma, Inc. financials

Frequently Asked Questions

What was Lyell Immunopharma, Inc.'s revenue in fiscal year 2025?

Lyell Immunopharma, Inc. generated $36K in revenue in fiscal year 2025.

How fast is Lyell Immunopharma, Inc.'s revenue growing?

Lyell Immunopharma, Inc. (LYEL) revenue fell by 41.0% year over year, from $61K to $36K in fiscal year 2025.

What is Lyell Immunopharma, Inc.'s revenue over the last twelve months?

Lyell Immunopharma, Inc. (LYEL) reported $27K in revenue over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

Across the 7 fiscal years this page covers, Lyell Immunopharma, Inc. (LYEL) revenue went from $657K in fiscal year 2019 to $36K in fiscal year 2025.

Lyell Immunopharma, Inc. (LYEL) reported $4K in revenue in Q2 2026. This represents a decrease of 50.0% from the same quarter a year earlier.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Lyell Immunopharma, Inc. (LYEL) reported on that line in every period on record.